Castres, France

Jean-Louis Vidaluc

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Pierre Fabre Medicament. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Louis Vidaluc. Retrieved from https://idiyas.com/inventor/jean-louis-vidaluc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jean-Louis Vidaluc: A Pioneer in Pharmaceutical Patents

Introduction

Jean-Louis Vidaluc, based in Castres, France, is a notable inventor in the field of pharmaceuticals. With a total of 2 patents to his name, he has made significant contributions to the development of novel therapeutic compounds. His work embodies the spirit of innovation and dedication to improving healthcare through scientific advancement.

Latest Patents

Vidaluc's most recent patents focus on groundbreaking chemical compounds with therapeutic applications. The first patent details the invention of 1,4-disubstituted piperidines, including their preparation and therapeutic uses. These compounds are defined by their formula and encompass therapeutically acceptable salts, showcasing their potential utility in treating various medical conditions.

Additionally, his second patent introduces new urea derivatives, revealing their preparation and therapeutic applications as well. The new compounds are characterized by a specific general formula where R¹ represents a C₁-C₄ alkyl group, indicating an innovative approach to drug development.

Career Highlights

Jean-Louis Vidaluc is currently associated with Pierre Fabre Medicament, a prominent company in the pharmaceutical sector. His role in this organization allows him to apply his inventive skills to advance medicinal chemistry and drug discovery, contributing to the development of effective therapeutic agents that can mitigate health challenges.

Collaborations

Throughout his career, Vidaluc has collaborated with esteemed colleagues, including Denis Bigg and Francis Calmel. These partnerships have fostered a collaborative environment that encourages innovative thinking and the sharing of expertise, ultimately leading to significant advancements in pharmaceutical inventions.

Conclusion

Jean-Louis Vidaluc stands as a testament to the impact of innovative thinking in the realm of pharmaceuticals. His patents not only illustrate his dedication to advancing healthcare but also highlight the importance of collaboration in scientific innovation. As he continues to work with Pierre Fabre Medicament, the potential for further groundbreaking inventions remains promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…